RLFTY — MindMaze Therapeutics Holding SA
—
OTC ·
Health Care ·
Pharmaceuticals ·
CIK 1854078 ·
Switzerland
Last close
$0.23
Market Cap
$39.25M
52W High
$4.05
52W Low
$0.23
ADV30
91
Next earnings
—
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | Gross profit | Op income | Net income | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Jun 2026 | — | — | — | — | 44,107,000 | 5,324,000 | 8,176,000 |
| Dec 2025 | — | — | — | — | 51,530,000 | 9,473,000 | 13,189,000 |
Balance + Analyst (yfinance extras)
Retained Earnings
$-17,384,000
Inventory
$896,000
Receivables
—
ST Investments
—
EBIT TTM
—
Pretax Income TTM
—
Interest Exp TTM
—
Analysts
—
Yahoo Snapshot (yfinance, live)
Total Revenue
$1,196,000
EBITDA
$-10,215,000
Free Cash Flow
—
Enterprise Value
$66,522,360
Total Cash
$5,324,000
Total Debt
$24,000
Shares Out
169,993,750
Trailing EPS
$-0.30
Book Value
$0.31
ROE
-51.6%
ROA
-25.5%
Div Yield
—
Annual Trend (SEC EDGAR, last 2y)
Revenues vs Net Income (last 2y)
| FY end | Revenues | Op income | Net income | Assets | Liabilities | Equity | Op cash flow |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 642,000 | -10,515,000 | -9,906,000 | 51,530,000 | 13,189,000 | 38,341,000 | -7,208,000 |
| Dec 2024 | 0 | -2,000 | -1,000 | 93,000 | 7,000 | 86,000 | -3,000 |
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| IXHL | Incannex Healthcare Inc. | $39.77M | $3.17 | — |
| VERU | VERU INC. | $42.11M | $2.47 | — |
| FLNA | FILANA THERAPEUTICS, INC. | $42.26M | $0.87 | — |
| LITS | Lite Strategy, Inc. | $42.87M | $1.41 | — |
| EDSA | Edesa Biotech, Inc. | $35.86M | $3.72 | — |
News headlines (Yahoo Finance, 1h cache)
OTC Markets Group Announces Agenda for Third Annual Global Markets Forum, October 7th & 8th
2026-10-05 12:35 · Yahoo
MindMaze Therapeutics Announces MindMotion Lite to Expand Home-Based Neurorehabilitation
2026-09-17 05:31 · Yahoo
MindMaze Therapeutics Reports 2026 Half-Year Results and Corporate Update
2026-08-27 05:32 · Yahoo
MindMaze Therapeutics Appoints Prof. John W. Krakauer as Strategic Advisor
2026-08-12 05:39 · Yahoo
MindMaze Therapeutics Completes Organizational Simplification and Provides Update on Neuro.io Equity Financing
2026-08-10 05:28 · Yahoo
MindMaze Therapeutics: Consolidating a Global Approach to Reimbursement for Next-Generation Therapeutics
2025-12-23 06:20 · Yahoo
Relief Therapeutics and NeuroX Complete Business Combination and Form MindMaze Therapeutics
2025-12-15 06:20 · Yahoo
Relief Therapeutics Shareholders Approve Business Combination with NeuroX
2025-11-14 17:40 · Yahoo
Relief Therapeutics Announces Positive Results from Pivotal Bioequivalence Study of RLF-OD032
2025-10-29 06:20 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.